+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Naproxen"

From
From
Acute Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Chronic Lower Back Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Lower Back Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
From
From
From
From
Pain and Fever Relief Drugs Markets in China - Product Thumbnail Image

Pain and Fever Relief Drugs Markets in China

  • Report
  • July 2023
  • 223 Pages
  • China
From
Global and Chinese Naproxen Sodium Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Naproxen Sodium Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 149 Pages
  • Global, China
From
Analgesics in Sweden - Product Thumbnail Image

Analgesics in Sweden

  • Report
  • October 2023
  • 24 Pages
  • Sweden
From
Loading Indicator

Naproxen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, inflammation, and fever. It is commonly used as an analgesic to treat mild to moderate pain, such as headaches, muscle aches, menstrual cramps, and arthritis. Naproxen is available in both over-the-counter and prescription forms. It is also available in combination with other medications, such as ibuprofen and acetaminophen. Naproxen is one of the most commonly used analgesics in the world. It is widely available in both generic and brand-name forms. It is also available in a variety of formulations, including tablets, capsules, liquids, and topical creams. Naproxen is a popular choice for treating pain due to its effectiveness and relatively low cost. It is also generally well-tolerated, with few side effects. However, it can cause stomach upset, nausea, and other gastrointestinal problems in some people. Some of the companies in the Naproxen market include Pfizer, GlaxoSmithKline, Bayer, Merck, and Novartis. Show Less Read more